BMS, GRYT partner in digital patient experience pilot

GRYT Health (Rochester, N.Y.) and Bristol-Myers Squibb Co. (NYSE:BMY) partnered to conduct a pilot program to integrate de-identified patient experience data from GRYT's Stupid Cancer app with BMS's clinical data to inform the pharma's clinical trial design and improve R&D and disease management protocols.

The app is a social support and health management tool that anonymously connects patients to provide peer support and targeted cancer information. GRYT co-founder and CEO Dave Fuehrer told BioCentury that BMS can conduct digital focus groups through the app and invite patients to complete surveys about their experiences. Most users of the app are breast cancer patients or their caregivers, according to Fuehrer...